{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T19:58:46Z","timestamp":1782763126543,"version":"3.54.5"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T00:00:00Z","timestamp":1742256000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T00:00:00Z","timestamp":1742256000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Basic Research Fund in Shenzhen Natural Science Foundation","award":["JCYJ20230807110317036"],"award-info":[{"award-number":["JCYJ20230807110317036"]}]},{"name":"the Seventh Affiliated Hospital of Sun Yat-sen University","award":["ZSQY202473524"],"award-info":[{"award-number":["ZSQY202473524"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ovarian Res"],"DOI":"10.1186\/s13048-025-01640-3","type":"journal-article","created":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T09:46:18Z","timestamp":1742291178000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Negligible serum anti-M\u00fcllerian hormone levels and successfully spontaneous pregnancy three times: a case report"],"prefix":"10.1186","volume":"18","author":[{"given":"Yiman","family":"Fu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baoyi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,18]]},"reference":[{"key":"1640_CR1","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1093\/humupd\/dmp036","volume":"16","author":"A La Marca","year":"2010","unstructured":"La Marca A, Sighinolfi G, Radi D, Argento C, Baraldi E, Artenisio AC, et al. Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART). Hum Reprod Update. 2010;16:113\u201330.","journal-title":"Hum Reprod Update"},{"key":"1640_CR2","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1210\/endrev\/bnab012","volume":"42","author":"N di Clemente","year":"2021","unstructured":"di Clemente N, Racine C, Pierre A, Taieb J. Anti-M\u00fcllerian hormone in female reproduction. Endocr Rev. 2021;42:753\u201382. https:\/\/doi.org\/10.1210\/endrev\/bnab012.","journal-title":"Endocr Rev"},{"key":"1640_CR3","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s10815-014-0193-4","volume":"31","author":"P Lehmann","year":"2014","unstructured":"Lehmann P, V\u00e9lez MP, Saumet J, Lapens\u00e9e L, Jamal W, Bissonnette F, et al. Anti-M\u00fcllerian hormone (AMH): a reliable biomarker of oocyte quality in IVF. J Assist Reprod Genet. 2014;31:493\u20138.","journal-title":"J Assist Reprod Genet"},{"key":"1640_CR4","doi-asserted-by":"publisher","first-page":"2824","DOI":"10.1016\/j.fertnstert.2010.04.067","volume":"94","author":"N Gleicher","year":"2010","unstructured":"Gleicher N, Weghofer A, Barad DH. Anti-M\u00fcllerian hormone (AMH) defines, independent of age, low versus good live-birth chances in women with severely diminished ovarian reserve. Fertil Steril. 2010;94:2824\u20137.","journal-title":"Fertil Steril"},{"key":"1640_CR5","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.ejogrb.2010.02.029","volume":"150","author":"K Majumder","year":"2010","unstructured":"Majumder K, Gelbaya TA, Laing I, Nardo LG. The use of anti-M\u00fcllerian hormone and antral follicle count to predict the potential of oocytes and embryos. Eur J Obstet Gynecol Reprod Biol. 2010;150:166\u201370.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"1640_CR6","doi-asserted-by":"publisher","first-page":"2414","DOI":"10.1093\/humrep\/dem204","volume":"22","author":"SM Nelson","year":"2007","unstructured":"Nelson SM, Yates RW, Fleming R. Serum anti-M\u00fcllerian hormone and FSH: prediction of live birth and extremes of response in stimulated cycles\u2013implications for individualization of therapy. Hum Reprod. 2007;22:2414\u201321.","journal-title":"Hum Reprod"},{"key":"1640_CR7","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/S1472-6483(10)61053-X","volume":"14","author":"DN Lekamge","year":"2007","unstructured":"Lekamge DN, Barry M, Kolo M, Lane M, Gilchrist RB, Tremellen KP. Anti-M\u00fcllerian hormone as a predictor of IVF outcome. Reprod Biomed Online. 2007;14:602\u201310.","journal-title":"Reprod Biomed Online"},{"key":"1640_CR8","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.fertnstert.2006.06.019","volume":"87","author":"JMJ Smeenk","year":"2007","unstructured":"Smeenk JMJ, Sweep FCGJ, Zielhuis GA, Kremer JAM, Thomas CMG, Braat DDM. Antim\u00fcllerian hormone predicts ovarian responsiveness, but not embryo quality or pregnancy, after in vitro fertilization or intracyoplasmic sperm injection. Fertil Steril. 2007;87:223\u20136.","journal-title":"Fertil Steril"},{"key":"1640_CR9","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.fertnstert.2007.12.013","volume":"91","author":"SL Broer","year":"2009","unstructured":"Broer SL, Mol BWJ, Hendriks D, Broekmans FJM. The role of antimullerian hormone in prediction of outcome after IVF: comparison with the antral follicle count. Fertil Steril. 2009;91:705\u201314.","journal-title":"Fertil Steril"},{"key":"1640_CR10","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1093\/humupd\/dml034","volume":"12","author":"FJ Broekmans","year":"2006","unstructured":"Broekmans FJ, Kwee J, Hendriks DJ, Mol BW, Lambalk CB. A systematic review of tests predicting ovarian reserve and IVF outcome. Hum Reprod Update. 2006;12:685\u2013718.","journal-title":"Hum Reprod Update"},{"key":"1640_CR11","first-page":"371","volume":"11","author":"R Dehghani-Firouzabadi","year":"2008","unstructured":"Dehghani-Firouzabadi R, Tayebi N, Asgharnia M. Serum level of anti-mullerian hormone in early follicular phase as a predictor of ovarian reserve and pregnancy outcome in assisted reproductive technology cycles. Arch Iran Med. 2008;11:371\u20136.","journal-title":"Arch Iran Med"},{"key":"1640_CR12","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1093\/humrep\/den108","volume":"23","author":"C Gnoth","year":"2008","unstructured":"Gnoth C, Schuring AN, Friol K, Tigges J, Mallmann P, Godehardt E. Relevance of anti-Mullerian hormone measurement in a routine IVF program. Hum Reprod. 2008;23:1359\u201365.","journal-title":"Hum Reprod"},{"key":"1640_CR13","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1093\/humrep\/deh718","volume":"20","author":"J Pe\u00f1arrubia","year":"2005","unstructured":"Pe\u00f1arrubia J, F\u00e1bregues F, Manau D, Creus M, Casals G, Casamitjana R, et al. Basal and stimulation day 5 anti-Mullerian hormone serum concentrations as predictors of ovarian response and pregnancy in assisted reproductive technology cycles stimulated with gonadotropin-releasing hormone agonist\u2013gonadotropin treatment. Hum Reprod. 2005;20:915\u201322.","journal-title":"Hum Reprod"},{"key":"1640_CR14","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1016\/j.fertnstert.2005.11.045","volume":"85","author":"A Prakash","year":"2006","unstructured":"Prakash A, Li TC, Laird S, Nargund G, Ledger WL. Absence of follicular phase defect in women with recurrent miscarriage. Fertil Steril. 2006;85:1784\u201390.","journal-title":"Fertil Steril"},{"key":"1640_CR15","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1093\/humrep\/den480","volume":"24","author":"SM Nelson","year":"2009","unstructured":"Nelson SM, Yates RW, Lyall H, Jamieson M, Traynor I, Gaudoin M, et al. Anti-M\u00fcllerian hormone-based approach to controlled ovarian stimulation for assisted conception. Hum Reprod. 2009;24:867\u201375.","journal-title":"Hum Reprod"},{"key":"1640_CR16","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1016\/j.fertnstert.2004.03.061","volume":"82","author":"A Hazout","year":"2004","unstructured":"Hazout A, Bouchard P, Seifer DB, Aussage P, Junca AM, Cohen-Bacrie P. Serum antim\u00fcllerian hormone\/m\u00fcllerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone, inhibin B, or estradiol. Fertil Steril. 2004;82:1323\u20139.","journal-title":"Fertil Steril"},{"key":"1640_CR17","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.cca.2006.06.013","volume":"375","author":"T Fr\u00e9our","year":"2007","unstructured":"Fr\u00e9our T, Miralli\u00e9 S, Bach-Ngohou K, Denis M, Barri\u00e8re P, Masson D. Measurement of serum anti-M\u00fcllerian hormone by Beckman Coulter ELISA and DSL ELISA: comparison and relevance in assisted reproduction technology (ART). Clin Chim Acta. 2007;375:162\u20134.","journal-title":"Clin Chim Acta"},{"key":"1640_CR18","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1007\/s10815-015-0595-y","volume":"32","author":"J Cohen","year":"2015","unstructured":"Cohen J, Chabbert-Buffet N, Darai E. Diminished ovarian reserve, premature ovarian failure, poor ovarian responder\u2014a plea for universal definitions. J Assist Reprod Genet. 2015;32:1709\u201312.","journal-title":"J Assist Reprod Genet"},{"key":"1640_CR19","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1210\/clinem\/dgac039","volume":"107","author":"MI Cedars","year":"2022","unstructured":"Cedars MI. Evaluation of female Fertility-AMH and ovarian reserve testing. J Clin Endocrinol Metab. 2022;107:1510\u20139.","journal-title":"J Clin Endocrinol Metab"},{"key":"1640_CR20","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.ejmg.2005.08.001","volume":"49","author":"F Pellestor","year":"2006","unstructured":"Pellestor F, Andr\u00e9o B, Anahory T, Hamamah S. The occurrence of aneuploidy in human: lessons from the cytogenetic studies of human oocytes. Eur J Med Genet. 2006;49:103\u201316.","journal-title":"Eur J Med Genet"},{"key":"1640_CR21","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.fertnstert.2007.06.023","volume":"90","author":"I Streuli","year":"2008","unstructured":"Streuli I, Fraisse T, Pillet C, Ibecheole V, Bischof P, de Ziegler D. Serum antim\u00fcllerian hormone levels remain stable throughout the menstrual cycle and after oral or vaginal administration of synthetic sex steroids. Fertil Steril. 2008;90:395\u2013400.","journal-title":"Fertil Steril"},{"key":"1640_CR22","unstructured":"Dewailly D. [Usefulness of inhibin B, serum progesterone, and AMH concentrations obtained during controlled ovarian hyperstimulation (COH) in predicting ovarian response and oocyte quality]. J Gynecol Obstet Biol Reprod (Paris) 2006;35:2S44-42S46."},{"key":"1640_CR23","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1093\/humrep\/dei270","volume":"21","author":"T Silberstein","year":"2006","unstructured":"Silberstein T, MacLaughlin DT, Shai I, Trimarchi JR, Lambert-Messerlian G, Seifer DB, et al. Mullerian inhibiting substance levels at the time of HCG administration in IVF cycles predict both ovarian reserve and embryo morphology. Hum Reprod. 2006;21:159\u201363.","journal-title":"Hum Reprod"},{"key":"1640_CR24","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/S1472-6483(10)60859-0","volume":"12","author":"IAJ van Rooij","year":"2006","unstructured":"van Rooij IAJ, Broekmans FJM, Hunault CC, Scheffer GJ, Eijkemans MJC, de Jong FH, et al. Use of ovarian reserve tests for the prediction of ongoing pregnancy in couples with unexplained or mild male infertility. Reprod Biomed Online. 2006;12:182\u201390.","journal-title":"Reprod Biomed Online"},{"key":"1640_CR25","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1001\/jama.2017.14588","volume":"318","author":"AZ Steiner","year":"2017","unstructured":"Steiner AZ, Pritchard D, Stanczyk FZ, Kesner JS, Meadows JW, Herring AH, et al. Association between biomarkers of ovarian reserve and infertility among older women of reproductive age. JAMA. 2017;318:1367\u201376.","journal-title":"JAMA"},{"key":"1640_CR26","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1080\/09513590.2017.1306848","volume":"33","author":"M Depmann","year":"2017","unstructured":"Depmann M, Broer SL, Eijkemans MJC, van Rooij IaJ, Scheffer GJ, Heimensem J, et al. Anti-M\u00fcllerian hormone does not predict time to pregnancy: results of a prospective cohort study. Gynecol Endocrinol. 2017;33:644\u20138.","journal-title":"Gynecol Endocrinol"},{"key":"1640_CR27","doi-asserted-by":"publisher","first-page":"4215","DOI":"10.1210\/jc.2015-2474","volume":"100","author":"SM Zarek","year":"2015","unstructured":"Zarek SM, Mitchell EM, Sjaarda LA, Mumford SL, Silver RM, Stanford JB, et al. Is Anti-M\u00fcllerian hormone associated with fecundability?? Findings from the eager trial. J Clin Endocrinol Metab. 2015;100:4215\u201321.","journal-title":"J Clin Endocrinol Metab"},{"key":"1640_CR28","doi-asserted-by":"publisher","first-page":"e7239","DOI":"10.1016\/j.fertnstert.2007.03.084","volume":"89","author":"T Fraisse","year":"2008","unstructured":"Fraisse T, Ibecheole V, Streuli I, Bischof P, de Ziegler D. Undetectable serum anti-M\u00fcllerian hormone levels and occurrence of ongoing pregnancy. Fertil Steril. 2008;89:e7239\u201311.","journal-title":"Fertil Steril"},{"key":"1640_CR29","doi-asserted-by":"publisher","first-page":"e3959","DOI":"10.1016\/j.fertnstert.2009.03.044","volume":"92","author":"A Tocci","year":"2009","unstructured":"Tocci A, Ferrero S, Iacobelli M, Greco E. Negligible serum anti-m\u00fcllerian hormone: pregnancy and birth after a 1-month course of an oral contraceptive, ovarian hyperstimulation, and intracytoplasmic sperm injection. Fertil Steril. 2009;92:e3959\u201339512.","journal-title":"Fertil Steril"},{"key":"1640_CR30","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s10815-019-01622-7","volume":"37","author":"J Bedenk","year":"2020","unstructured":"Bedenk J, Vrta\u010dnik-Bokal E, Virant-Klun I. The role of anti-M\u00fcllerian hormone (AMH) in ovarian disease and infertility. J Assist Reprod Genet. 2020;37:89\u2013100.","journal-title":"J Assist Reprod Genet"},{"key":"1640_CR31","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1093\/humrep\/dev145","volume":"30","author":"M D\u00f3lleman","year":"2015","unstructured":"D\u00f3lleman M, Verschuren WMM, Eijkemans MJC, Broekmans FJM, van der Schouw YT. Added value of anti-M\u00fcllerian hormone in prediction of menopause: results from a large prospective cohort study. Hum Reprod. 2015;30:1974\u201381.","journal-title":"Hum Reprod"},{"key":"1640_CR32","doi-asserted-by":"publisher","first-page":"5024","DOI":"10.1210\/jc.2018-02607","volume":"104","author":"AC de Kat","year":"2019","unstructured":"de Kat AC, van der Schouw YT, Eijkemans MJC, Broer SL, Verschuren WMM, Broekmans FJM. Can menopause prediction be improved with multiple AMH measurements?? Results from the prospective Doetinchem cohort study. J Clin Endocrinol Metab. 2019;104:5024\u201331.","journal-title":"J Clin Endocrinol Metab"},{"key":"1640_CR33","doi-asserted-by":"publisher","first-page":"e1862","DOI":"10.1210\/clinem\/dgz283","volume":"105","author":"JS Finkelstein","year":"2020","unstructured":"Finkelstein JS, Lee H, Karlamangla A, Neer RM, Sluss PM, Burnett-Bowie S-AM, et al. Antimullerian hormone and impending menopause in late reproductive age: the study of women\u2019s health across the Nation. J Clin Endocrinol Metab. 2020;105:e1862\u20131871.","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Journal of Ovarian Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-025-01640-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13048-025-01640-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-025-01640-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T09:46:28Z","timestamp":1742291188000},"score":1,"resource":{"primary":{"URL":"https:\/\/ovarianresearch.biomedcentral.com\/articles\/10.1186\/s13048-025-01640-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,18]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1640"],"URL":"https:\/\/doi.org\/10.1186\/s13048-025-01640-3","relation":{},"ISSN":["1757-2215"],"issn-type":[{"value":"1757-2215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,18]]},"assertion":[{"value":"11 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for the publication of this case report.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"57"}}